Fig. 1.
Survival curves for the metformin group (solid line) and nonmetformin group (dotted line) in patients with resectable (panel A), unresectable (panel B), and metastatic (panel C) pancreatic cancer. P values (log rank test) were 0.293, 0.001, and 0.482 for panels A, B, and C, respectively.